{"id":"JGAD000927","research":"hum0311","url":"https://humandbs.dbcls.jp/dataset/JGAD000927","datePublished":"2025-06-13","dateModified":"2025-06-13","values":[{"key":"access-criteria","label":{"ja":"アクセス制限","en":"Access criteria"},"type":"vocabulary","terms":[{"code":"controlled-access-type-1","label":{"ja":"制限公開（Type I）","en":"Controlled-access (Type I)"}}]},{"key":"type-of-data","label":{"ja":"データの種類","en":"Type of data"},"type":"text","text":{"ja":"BBJ第一コホート3,050名の血清サンプルを対象としたプロテオミクス解析データ","en":"Proteome data for 3,050 BBJ participants from BBJ 1st cohort"}}],"experiments":[{"label":"Proteomics (Olink 2926/1196 + SomaScan 7596 proteins)","values":[{"key":"materials-and-participants","label":{"ja":"材料と対象者","en":"Materials and participants"},"type":"text","text":{"ja":"BBJ第一コホート 3,050名 （ICD10：C169、C189、C20、C509、C61、I219、L270）\n（1） 2,962名（東京大学にて解析）\n（2） 上記2,962名に含まれる256名（東京大学にて解析）\n（3） 上記2,962名かつ256名に含まれる82名（FonesLife社にて解析）\n（4） 上記とは別の88名（タカラバイオ社にて解析）","en":"3,050 participants for BBJ 1st cohort (ICD10: C169, C189, C20, C509, C61, I219, L270)\n(1) 2,962 participants analyzed at the University of Tokyo\n(2) 256 subjects as included in the above 2,962 BBJ 1st participants analyzed at the University of Tokyo\n(3) 82 subjects as included in the above 2,962 or 256 BBJ 1st participants analyzed at FonesLife Corporation\n(4) another 88 BBJ 1st participant analyzed at Takara Bio Corporation"}},{"key":"disease","label":{"ja":"疾患","en":"Disease"},"type":"disease","diseases":[{"terms":[{"code":"C169","label":{"ja":"胃，部位不明","en":"Malignant neoplasm: Stomach, unspecified"}},{"code":"C189","label":{"ja":"結腸，部位不明","en":"Malignant neoplasm: Colon, unspecified"}},{"code":"C20","label":{"ja":"直腸の悪性新生物＜腫瘍＞","en":"Malignant neoplasm of rectum"}},{"code":"C509","label":{"ja":"乳房，部位不明","en":"Malignant neoplasm: Breast, unspecified"}},{"code":"C61","label":{"ja":"前立腺の悪性新生物＜腫瘍＞","en":"Malignant neoplasm of prostate"}},{"code":"I219","label":{"ja":"急性心筋梗塞，詳細不明","en":"Acute myocardial infarction, unspecified"}},{"code":"L270","label":{"ja":"薬物及び薬剤による全身の発疹","en":"Generalized skin eruption due to drugs and medicaments"}}],"name":{"ja":"BBJ第一コホート","en":"participants for BBJ 1st cohort"}}]},{"key":"health-status","label":{"ja":"健康状態","en":"Health status"},"type":"vocabulary","terms":[{"code":"affected","label":{"ja":"罹患","en":"Affected"}}]},{"key":"subject-count","label":{"ja":"対象者数","en":"Subject count"},"type":"number","numbers":[{"value":3050,"unit":null,"high":null}]},{"key":"subject-count-type","label":{"ja":"対象者数の数え方","en":"Counted as"},"type":"vocabulary","terms":[{"code":"individual","label":{"ja":"人数","en":"Individual"}}]},{"key":"cohort","label":{"ja":"コホート","en":"Cohort"},"type":"vocabulary","terms":[{"code":"biobank-japan","label":{"en":"BioBank Japan"}}]},{"key":"sample-description","label":{"ja":"試料説明","en":"Sample description"},"type":"text","text":{"ja":"血清サンプル","en":"serum samples"}},{"key":"tissue","label":{"ja":"組織","en":"Tissue"},"type":"vocabulary","terms":[{"code":"serum","label":{"ja":"血清","en":"Serum"}}]},{"key":"is-tumor","label":{"ja":"腫瘍 / 非腫瘍","en":"Tumor / normal"},"type":"vocabulary","terms":[{"code":"normal","label":{"ja":"非腫瘍","en":"Normal"}}]},{"key":"sample-provider","label":{"ja":"試料の入手元","en":"Sample provider"},"type":"text","text":{"ja":null,"en":null}},{"key":"experimental-method","label":{"ja":"実験方法","en":"Experimental method"},"type":"vocabulary","terms":[{"code":"proteomics","label":{"en":"Proteomics"}}]},{"key":"targets","label":{"ja":"測定対象","en":"Target"},"type":"text","text":{"ja":null,"en":null}},{"key":"reagents","label":{"ja":"試薬キット","en":"Reagent kit"},"type":"vocabulary","terms":[{"code":"olink-explore-3072","label":{"en":"Olink Explore 3072"}},{"code":"olink-target-96","label":{"en":"Olink Target 96"}},{"code":"somascan","label":{"en":"SomaScan"}}]},{"key":"platform","label":{"ja":"プラットフォーム","en":"Platform"},"type":"vocabulary","terms":[{"code":"olink-explore-3072","label":{"en":"Olink Explore 3072"}},{"code":"olink-target-96","label":{"en":"Olink Target 96"}},{"code":"somalogic-somascan","label":{"en":"SomaLogic SomaScan"}}]},{"key":"normalization","label":{"ja":"正規化","en":"Normalization"},"type":"text","text":{"ja":"（1） 各バッチ内でIntensity normalization、および3つのバッチにわたる24サンプルを用いたbridge normalization\n（2） Intensity normalization\n（3） Adaptive Normalization by Maximum Likelihood（ANML）\n（4） Plate normalization","en":"(1) Intensity normalization within each batch, and bridge normalization using 24 samples across 3 batches\n(2) Intensity normalization\n(3) Adaptive Normalization by Maximum Likelihood (ANML)\n(4) Plate normalization"}},{"key":"analysis-methods","label":{"ja":"解析方法","en":"Analysis method"},"type":"text","text":{"ja":"（1） Olink NPX Explore v1.7.1\n（2） Olink NPX Signature 1.7.0.0\n（3） 検出は製造元によって実施\n（4） Olink NPX Explore v1.7.1","en":"(1) Olink NPX Explore v1.7.1\n(2) Olink NPX Signature 1.7.0.0\n(3) Detection was conducted by the manufacturer\n(4) Olink NPX Explore v1.7.1"}},{"key":"policies","label":{"ja":"利用ポリシー","en":"Data use policy"},"type":"vocabulary","terms":[{"code":"nbdc-data-sharing-policy-jgap000001","label":{"ja":"NBDC データ共有ポリシー (JGAP000001)","en":"NBDC data sharing policy (JGAP000001)"}}]}]}],"dataVolume":477853820,"fileFormats":[{"code":"adat","label":{"en":"ADAT"}},{"code":"npx","label":{"en":"NPX"}},{"code":"csv","label":{"en":"CSV"}},{"code":"pptx","label":{"en":"PPTX"}},{"code":"tar","label":{"en":"TAR"}}]}